Breaking News, Collaborations & Alliances

Recro, Teva Extend License and Supply Agreement

CDMO Recro Gainesville will continue to supply Verapamil SR capsules through 2024

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Recro Gainesville, the contract development and manufacturing organization (CDMO) division of Recro Pharma, has amended its existing license and supply agreement with Teva Pharmaceutical to extend the agreement for six years, effective January 1, 2019.   Under the terms of the amended agreement, Recro Gainesville will continue to supply Teva with Verapamil SR capsules through 2024 and Teva will continue to be Recro Gainesville’s exclusive U.S. distributor of the product, for which Recro Gainesvi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters